ICCC

ImmuCell Corporation (NASDAQ:ICCC) is a specialized animal health company founded in 1982 and headquartered in Portland, Maine. The company went public in 1987 and has spent over four decades developing, manufacturing, and marketing products specifically designed to enhance the health and productivity of dairy and beef cattle. ImmuCell operates in the niche animal health biotechnology sector, focusing on preventive care solutions for newborn calves and treatment products for dairy cow health issues. The company has invested 25 years and approximately $50 million in developing its flagship Re-Tain product, which awaits FDA approval as a revolutionary alternative to traditional antibiotics for treating subclinical mastitis in dairy cows.